Celyad Oncology SA Sustainability Reports
Celyad Oncology S.A. is a biopharmaceutical company focused on the discovery and development of CAR-T cell therapies for cancer treatment.
Sector: Health Care
Country: Belgium
Exchange: Euronext Brussels
ISIN: BE0974260896
6 reports from 2015 to 2022
Company Profile
Celyad Oncology SA
Celyad Oncology S.A. is a biopharmaceutical company focused on the discovery and development of CAR-T cell therapies for cancer treatment.
Reports